Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Vinci $250M Series BDevoted Health $555M Series GRanked by rounds participated in, from announcements in Oct 1, 2026 – Oct 31, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Vinci $250M Series BDevoted Health $555M Series GNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Mecka $60M Series BGraduate Ventures Seed Fund II ~€100M Second seed fund first closeNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Healthleap $30M Series AConway Research Undisclosed First financingNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Sensible Biotechnologies $47M Series AFoundational £8.2M Pre-seedNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Vates €30M First external growth investmentWiremind €35M First external financingNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Seed 1
Walapay $4.6M SeedFronte Undisclosed Pre-seedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Farmnote Undisclosed Impact equity investmentNessu ¥90M Series A first closeNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Pandektes €13.5M Series ADeepslate €7.7M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Namespace $42M Series BVolantis $88M Series ANew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Supabase Undisclosed Funding roundDevoted Health $555M Series GNew companies 2 · Follow-on 0
Stages: Undisclosed 2
LAUNCHub Fund III €65M Fund first closeHeadline EU VIII $400M Venture capital fund final close“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.